Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$480K Sell
9,955
-195
-2% -$10K 0.03% 672
2026
Q2
$532K Buy
10,150
+1,101
+12% +$58.2K 0.05% 484
2026
Q1
$499K Buy
9,049
+1,463
+19% +$79.3K 0.09% 254
2025
Q4
$372K Buy
+7,586
New +$354K 0.11% 183

Other funds holding GSK

Frec Markets's GSK Position: Q3 2026 in Review

Frec Markets reduced its GSK (GSK) stake by 1.9% in Q3 2026, selling an estimated $10K and leaving 9,955 shares worth $480K. The position accounts for 0.03% of the portfolio, ranked #672.

Frec Markets first reported a position in GSK in Q4 2025 and has held it in 4 quarters since. The position peaked at $532K in Q2 2026. 993 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Frec Markets held 9,955 shares of GSK worth $480K as of Q3 2026.
  • Frec Markets sold 195 GSK shares in Q3 2026, an estimated $10K.
  • GSK made up 0.03% of Frec Markets's portfolio in Q3 2026, its #672 holding.
  • Frec Markets first reported a position in GSK in Q4 2025 and has held it in 4 quarters since.
  • Frec Markets's GSK position peaked at $532K in Q2 2026.
  • 993 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Frec Markets's 13F filing for Q3 2026, filed 16 Nov 2026.